SL Science Replaces ARK Pro CPA with TAAD LLP as Independent Auditor
SLBT is trading near its 52-week low of $2.537 (7.6% above the low).
Summary
SL Science replaced its auditor ARK Pro CPA & Co with TAAD LLP effective August 21, 2026, citing no disagreements, while confirming ARK's prior audit report contained a going-concern explanatory paragraph.
Key Events · Corporate Governance and Compliance · SLBT
-
Auditor Change
ARK Pro CPA & Co was dismissed on August 20, 2026, and TAAD LLP was appointed the next day, with the audit committee's approval.
-
Going-Concern Reference
ARK's audit report on the Company included an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern.
-
No Disagreements
There were no disagreements or reportable events with ARK regarding accounting principles, financial statement disclosure, or auditing scope or procedure.
-
Prior Financial Distress
This follows the June 18, 2026 20-F, which disclosed going-concern language and a 221% increase in net loss to $(3.82) million.
Analysis · SLBT · Life Sciences
On August 20, 2026, SL Science Holding Ltd dismissed ARK Pro CPA & Co and appointed TAAD LLP the following day. While the filing reports no disagreements or reportable events with ARK, it also confirms that ARK's audit report on the Company included an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern. That going-concern language, first disclosed in the June 18, 2026 20-F, is now reaffirmed in the context of an auditor change — a combination that raises governance and financial-distress concerns for a company that completed its SPAC merger only two months ago.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLBT was trading at $2.73 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $2.54 to $14.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.